個股熱度排行 | 5月24日港股盤前
根據uSMART輿情監測數據，從23日晚間到24日港股盤前時間段，市場關注指數最高的5只股票是小鵬汽車-W、東方海外國際、君實生物、中國生物製藥、協鑫科技。
5月24日—港股關注排行TOP5
小鵬汽車-W
關注度第一爲小鵬汽車-W，該股上個交易日收盤下跌6.53%，報於90.85港元。近5個交易日累計上漲2.54%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
小鵬汽車-W第一季度總收入74.55億元 汽車總交付量爲34561輛
小鵬汽車明年推兩款新車，整體將覆蓋 15 萬至 40 萬元價格區間
東方海外國際
關注度第二爲東方海外國際，該股上個交易日收盤上漲6.33%，報於258.80港元。近5個交易日累計上漲12.52%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
時富金融短炒東方海外、持貨一週即沽貨 賬面收益100萬
時富金融服務集團出售總共6.2萬股東方海外股份
君實生物
關注度第三爲君實生物，該股上個交易日收盤下跌5.17%，報於55.00港元。近5個交易日累計下跌6.78%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
君實生物：VV116對比PAXLOVID早期治療輕中度COVID-19的III期註冊臨牀研究達到主要研究終點
君實生物：VV116新冠口服藥重要臨牀研究達到主要終點 即將溝通上市申請事宜
中國生物製藥
關注度第四爲中國生物製藥，該股上個交易日收盤上漲1.41%，報於4.31港元。近5個交易日累計上漲9.11%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
中國生物製藥：TQ-B3139已向國家藥監局申報上市並獲受理
中國生物製藥已累計購回本金總額2.6億歐元債券
協鑫科技
關注度第五爲協鑫科技，該股上個交易日收盤上漲0.76%，報於2.64港元。近5個交易日累計上漲12.34%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
協鑫科技：正考慮及探討發行A股可行性
協鑫科技：擬探討A股上市可行性 尚未申請發行A股
此外，監測期內有1只股票的輿情出現大扭轉，意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。
5月24日—港股輿情轉折預警
東方海外國際
東方海外國際輿情扭轉指數達100，目前輿情方向爲利空，表明公司出現了被投資者視作較大利空的消息。
其中較被市場關注的消息有：
時富金融短炒東方海外、持貨一週即沽貨 賬面收益100萬
時富金融服務集團出售總共6.2萬股東方海外股份
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
